156 related articles for article (PubMed ID: 33906311)
1. The Clinical Value of VDR and CTLA 4 in Evaluating the Prognosis of Invasive Duct Carcinoma of Egyptian Patients and their Benefit as a Target Therapy.
Holah NS
Asian Pac J Cancer Prev; 2021 Apr; 22(4):1183-1194. PubMed ID: 33906311
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of proliferating cell nuclear antigen (PCNA) in infiltrating ductal carcinoma breast.
Aziz SA; Pervez S; Khan SM; Kayani N; Nasir MI
J Coll Physicians Surg Pak; 2005 Apr; 15(4):225-9. PubMed ID: 15857596
[TBL] [Abstract][Full Text] [Related]
3. Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions.
Lopes N; Sousa B; Martins D; Gomes M; Vieira D; Veronese LA; Milanezi F; Paredes J; Costa JL; Schmitt F
BMC Cancer; 2010 Sep; 10():483. PubMed ID: 20831823
[TBL] [Abstract][Full Text] [Related]
4. Prognostic role of vitamin D receptor in breast cancer: a systematic review and meta-analysis.
Xu H; Liu Z; Shi H; Wang C
BMC Cancer; 2020 Nov; 20(1):1051. PubMed ID: 33131491
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D receptor expression in invasive breast tumors and breast cancer survival.
Huss L; Butt ST; Borgquist S; Elebro K; Sandsveden M; Rosendahl A; Manjer J
Breast Cancer Res; 2019 Jul; 21(1):84. PubMed ID: 31358030
[TBL] [Abstract][Full Text] [Related]
6. Association of SNP-SNP Interactions Between RANKL, OPG, CHI3L1, and VDR Genes With Breast Cancer Risk in Egyptian Women.
Shaker OG; Senousy MA
Clin Breast Cancer; 2019 Feb; 19(1):e220-e238. PubMed ID: 30309792
[TBL] [Abstract][Full Text] [Related]
7. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.
Bandić D; Juretić A; Sarcević B; Separović V; Kujundzić-Tiljak M; Hudolin T; Spagnoli GC; Cović D; Samija M
Croat Med J; 2006 Feb; 47(1):32-41. PubMed ID: 16489695
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D Receptor in Breast Cancer Tissues and Its Relation to Estrogen Receptor Alpha (ER-α) Gene Expression and Serum 25-hydroxyvitamin D Levels in Egyptian Breast Cancer Patients: A Case-control Study.
Hemida MA; AbdElmoneim NA; Hewala TI; Rashad MM; Abdaallah S
Clin Breast Cancer; 2019 Jun; 19(3):e407-e414. PubMed ID: 30833174
[TBL] [Abstract][Full Text] [Related]
9. Progranulin (GP88) tumor tissue expression is associated with increased risk of recurrence in breast cancer patients diagnosed with estrogen receptor positive invasive ductal carcinoma.
Serrero G; Hawkins DM; Yue B; Ioffe O; Bejarano P; Phillips JT; Head JF; Elliott RL; Tkaczuk KR; Godwin AK; Weaver J; Kim WE
Breast Cancer Res; 2012 Feb; 14(1):R26. PubMed ID: 22316048
[TBL] [Abstract][Full Text] [Related]
10. Tumor Expression of Vitamin D Receptor and Breast Cancer Histopathological Characteristics and Prognosis.
Al-Azhri J; Zhang Y; Bshara W; Zirpoli G; McCann SE; Khoury T; Morrison CD; Edge SB; Ambrosone CB; Yao S
Clin Cancer Res; 2017 Jan; 23(1):97-103. PubMed ID: 27407090
[TBL] [Abstract][Full Text] [Related]
11. [Clinical characteristics and prognosis of breast cancer patients with vascular invasion].
Zhao WH; Xu BH; Zhang P; Li Q; Zhao LM; Sun Y
Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):137-40. PubMed ID: 17645853
[TBL] [Abstract][Full Text] [Related]
12. Expression of c-met is a strong independent prognostic factor in breast carcinoma.
Ghoussoub RA; Dillon DA; D'Aquila T; Rimm EB; Fearon ER; Rimm DL
Cancer; 1998 Apr; 82(8):1513-20. PubMed ID: 9554529
[TBL] [Abstract][Full Text] [Related]
13. Expression of CD 133 in Invasive Ductal Carcinoma of Breast.
Utnal PA; A H; Pn S; Gn M
Asian Pac J Cancer Prev; 2020 Oct; 21(10):3055-3059. PubMed ID: 33112567
[TBL] [Abstract][Full Text] [Related]
14. Association of Fascin and matrix metalloproteinase-9 expression with poor prognostic parameters in breast carcinoma of Egyptian women.
Youssef NS; Hakim SA
Diagn Pathol; 2014 Jul; 9():136. PubMed ID: 24993803
[TBL] [Abstract][Full Text] [Related]
15. Serum sFas and tumor tissue FasL negatively correlated with survival in Egyptian patients suffering from breast ductal carcinoma.
El-Sarha AI; Magour GM; Zaki SM; El-Sammak MY
Pathol Oncol Res; 2009 Jun; 15(2):241-50. PubMed ID: 19015953
[TBL] [Abstract][Full Text] [Related]
16. Incomplete inside-out growth pattern in invasive breast carcinoma: association with lymph vessel invasion and recurrence-free survival.
Kuba S; Ohtani H; Yamaguchi J; Hayashi H; Uga T; Kanematsu T; Shimokawa I
Virchows Arch; 2011 Feb; 458(2):159-69. PubMed ID: 21221635
[TBL] [Abstract][Full Text] [Related]
17. Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer.
Mercogliano MF; Inurrigarro G; De Martino M; Venturutti L; Rivas MA; Cordo-Russo R; Proietti CJ; Fernández EA; Frahm I; Barchuk S; Allemand DH; Figurelli S; Deza EG; Ares S; Gercovich FG; Cortese E; Amasino M; Guzmán P; Roa JC; Elizalde PV; Schillaci R
BMC Cancer; 2017 Dec; 17(1):895. PubMed ID: 29281999
[TBL] [Abstract][Full Text] [Related]
18. Expression of immune checkpoint regulators, cytotoxic T lymphocyte antigen 4 (CTLA-4) and programmed death-ligand 1 (PD-L1), in female breast carcinomas.
Kassardjian A; Shintaku PI; Moatamed NA
PLoS One; 2018; 13(4):e0195958. PubMed ID: 29672601
[TBL] [Abstract][Full Text] [Related]
19. Morphometric and immunohistochemical study of angiogenic marker expressions in invasive ductal carcinoma of human breast.
Safwat MD; Habib F; Elayat A; Oweiss N; Reffat S; Algaidi S
Folia Morphol (Warsz); 2009 Aug; 68(3):144-55. PubMed ID: 19722158
[TBL] [Abstract][Full Text] [Related]
20. PRSS3 is a prognostic marker in invasive ductal carcinoma of the breast.
Qian L; Gao X; Huang H; Lu S; Cai Y; Hua Y; Liu Y; Zhang J
Oncotarget; 2017 Mar; 8(13):21444-21453. PubMed ID: 28423522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
